Fundamentals of cancer metabolism
Open accessThe DOI matches its Crossref record; 203 of the 204 references it cites were found in a registry or an index.
Abstract
Tumors reprogram pathways of nutrient acquisition and metabolism to meet the bioenergetic, biosynthetic, and redox demands of malignant cells. These reprogrammed activities are now recognized as hallmarks of cancer, and recent work has uncovered remarkable flexibility in the specific pathways activated by tumor cells to support these key functions. In this perspective, we provide a conceptual framework to understand how and why metabolic reprogramming occurs in tumor cells, and the mechanisms linking altered metabolism to tumorigenesis and metastasis. Understanding these concepts will progressively support the development of new strategies to treat human cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IDH1/2 mutations have been identified in a range of tumor types, including solid tumors (e.g., gliomas and chondrosarcomas) and blood cancers like acute myelogenous leukemia (169, 170, 171).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“we propose that pharmacological ascorbate can potentially circumvent this problem by exploring two common features of cancer cells: their increased levels of labile transition metals, especially iron21, and their increased reliance on glucose uptake and glycolysis22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
The cited source says what the claim attributes to it.
In the citing paper
“Alternatively, certain cancer cells may use carbon sources such as glutamine or acetate to compensate for the reduction in acetyl-CoA synthesis from glucose [94,95].”
From HIF-1-Independent Mechanisms Regulating Metabolic Adaptation in Hypoxic Cancer Cells (2021) · cites this paper as [95]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Increased aerobic glycolysis is frequently observed in BAP1+/− cells [141], also analyzing the plasmatic metabolic profiles of individuals carrying different germline BAP1 mutations in comparison to BAP1 wild-type (BAP1WT) controls derived from two families [140].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [141]
Experimental — accuracy not yet measuredIn the citing paper
“Tumour cells exhibit a high rate of glycolysis, even in conditions with ample oxygen — a phenomenon that was first described by Otto Warburg, nearly a century ago22.”
From Targeting cancer vulnerabilities with high-dose vitamin C (2019) · cites this paper as [22]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · cited 21×
“When tumor cells become nutrient-deprived, they adapt to the microenvironment by decreasing their demand for ATP.”
BackgroundInfluentialmTOR Signaling in Growth Control and Disease
Laplante, M., & Sabatini, D. M. (2012) · Cell · doi:10.1016/j.cell.2012.03.017 · Cited by 8,509 · cited 2×
“mTORC1 is stimulated by the presence of amino acids and activates protein synthesis via its effects on translation and ribosome biogenesis (80).”
BackgroundHow mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · cited 1×
“ROS are intracellular chemical species that contain oxygen and include the superoxide anion (O2 ), hydrogen peroxide (H2O2), and the hydroxyl radical (OH·) (114).”
BackgroundThe emerging hallmarks of cancer metabolism
Pavlova, N. N., & Thompson, C. B. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2015.12.006 · Cited by 5,926 · cited 2×
“Because some altered metabolic features are observed quite generally across many types of cancer cells, reprogrammed metabolism is considered a hallmark of cancer (1, 2).”
BackgroundIDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645 · cited 1×
“Themetabolic adaptation to hypoxia is coordinated by HIF-1, which induces metabolic genes involved in increasing glycolytic flux (23).”
Background
Cited by
Items 801–900 of 1,007
Inorganic Nanobiomaterials Boost Tumor Immunotherapy: Strategies and Applications
Meng, Q., Ding, B., Ma, P., & Lin, J. (2025) · Accounts of Chemical Research · doi:10.1021/acs.accounts.4c00843 · Cited by 36
Xiang, J., Zhou, L., Zhuang, Y., Zhang, J., Sun, Y. N., Li, S., Zhang, Z., Zhang, G., & He, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6658 · Cited by 38
“Many molecules, such as MYC, the oncogene Kras, and the tumor suppressor TP53, regulate metabolic glycolysis and oxidative stress (6), although their underlying molecular mechanisms are unclear.”
BackgroundTumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells
Maimouni, S., Issa, N. T., Cheng, S., Ouaari, C., Cheema, A. K., Kumar, D., & Byers, S. W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208756 · Cited by 39
The Many Facets of Tumor Heterogeneity: Is Metabolism Lagging Behind?
Loponte, S., Lovisa, S., Deem, A. K., Carugo, A., & Viale, A. (2019) · Cancers · doi:10.3390/cancers11101574 · Cited by 40
“Tumors exploit this metabolic flexibility to escape environmental pressures, including drug treatment, which has recently been demonstrated by the inefficiency of cancer metabolism therapies [137,138].”
BackgroundMitochondrial metabolism and cancer metastasis
Yu, D., Liu, C., & Guo, L. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.03.42 · Cited by 37
“Involved in the first ratelimiting process of glycolysis, phosphofructokinase platelet (PFKP) can also be suppressed by Snail, which would shift the glucose flux more to the pentose phosphate pathway, leading to more NADPH production (24,25).”
BackgroundEscalona, E., Muñoz, M., Pincheira, R., Elorza, Á. A., & Castro, A. F. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01123 · Cited by 37
“Thus, tumor progression success depends on the capacity of cancer cells to adapt and surpass this metabolic challenge (2).”
BackgroundMiR-7 mediates mitochondrial impairment to trigger apoptosis and necroptosis in Rhabdomyosarcoma
Yang, L., Kong, D., He, M., Gong, J., Nie, Y., Tai, S., & Teng, C. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118826 · Cited by 38
Wen, X., Ou, Y., Bogatcheva, G. T., Thomas, G., Mahadevan-Jansen, A. M., Singh, B., Lin, E. C., & Bardhan, R. (2020) · Chemical Science · doi:10.1039/d0sc02221g · Cited by 34
Tu, M., Duan, Z., Liu, Z., Zhang, C., Bold, R. J., Gonzalez, F. J., Kim, E. J.-H., & Yu, A. (2020) · Molecular Pharmacology · doi:10.1124/molpharm.120.000130 · Cited by 39
Modulating NK cell metabolism for cancer immunotherapy
Terrén, I., Orrantia, A., Vitallé, J., Astarloa-Pando, G., Zenarruzabeitia, O., & Borrego, F. (2020) · Seminars in Hematology · doi:10.1053/j.seminhematol.2020.10.003 · Cited by 41
Klepinina, L., Klepinin, A., Truu, L., Chekulayev, V. A., Vija, H., Kuus, K., Teino, I., Pook, M., Maimets, T., & Käämbre, T. (2021) · PLoS ONE · doi:10.1371/journal.pone.0245348 · Cited by 37
“In contrast to normal cells, cancer cells often enhance glycolytic flux that supports cells with sufficient level of energy and intermediates for the biosynthetic pathways required for rapidly proliferating cells [69].”
BackgroundRole of LncRNAs in regulating cancer amino acid metabolism
Guo, Y., Lv, B., Liu, R., Dai, Z., Zhang, F., Liang, Y., Yu, B., Zeng, D., Lv, X., & Zhang, Z. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01926-8 · Cited by 38
Metabolic and hormonal remodeling of colorectal cancer cell signalling by diabetes
Gutiérrez‐Salmerón, M. T., Lucena, S. R., Chocarro‐Calvo, A., García-Martínez, J. M., Orozco, R. M. M., & García‐Jiménez, C. (2021) · Endocrine Related Cancer · doi:10.1530/erc-21-0092 · Cited by 38
Mondal, P., Gadad, S. S., Adhikari, S., Ramos, E., Sen, S., Prasad, P., & Das, C. (2021) · The FASEB Journal · doi:10.1096/fj.202002486rr · Cited by 37
Hypoxia in Cancer and Fibrosis: Part of the Problem and Part of the Solution
Romero, Y., & Aquino‐Gálvez, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158335 · Cited by 41
“For example, other intermediates of the tricarboxylic acid cycle (TCA) are used in macromolecule synthesis [47].”
BackgroundActive mitochondrial respiration in cancer: a target for the drug
Bedi, M., Ray, M., & Ghosh, A. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04281-4 · Cited by 36
Unravelling the Anticancer Mechanisms of Traditional Herbal Medicines with Metabolomics
Oyenihi, O. R., Oyenihi, A. B., Erhabor, J. O., Matsabisa, M. G., & Oguntibeju, O. O. (2021) · Molecules · doi:10.3390/molecules26216541 · Cited by 42
“Lipid uptake may be essential during conditions of metabolic stress when the ability to meet oncogene-driven demands for biosynthesis is compromised [38].”
BackgroundLRP5 Promotes Gastric Cancer via Activating Canonical Wnt/β-Catenin and Glycolysis Pathways
Nie, X., Wang, H., Wei, X., Li, L., Xue, T., Fan, L., Ma, H., Xia, Y., Wang, Y., & Chen, W. (2021) · American Journal Of Pathology · doi:10.1016/j.ajpath.2021.11.007 · Cited by 39
Sun, Q., Yuan, M., Wang, H., Zhang, X., Zhang, R., Wang, H., Chen, X., Zhu, M., Liu, S., & Wu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.767116 · Cited by 38
“Cell metabolic reprogramming exist in various cancer cells and are implicated as salient hallmarks of cancer (6).”
BackgroundFBXW7 and the Hallmarks of Cancer: Underlying Mechanisms and Prospective Strategies
Shen, W., Zhou, Q., Peng, C., Li, J., Yuan, Q., Zhu, H., Zhao, M., Jiang, X., Liu, W., & Ren, C. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.880077 · Cited by 49
“Evidence has shown that the activation of mTORC1 promotes nucleotide synthesis as well as glutaminolysis (118).”
BackgroundMethodInfluentialYousuf, M., Alam, M., Shamsi, A., Κhan, P., Hasan, G. M., Haque, Q. M. R., & Hassan, M. I. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.07.156 · Cited by 37
Posttranslational control of lipogenesis in the tumor microenvironment
Zhu, Y., Lin, X., Zhou, X., Prochownik, E. V., Wang, X., & Li, Y. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01340-1 · Cited by 42
“The metabolic changes that accompany tumor cells have attracted particular attention, especially with regard to how such changes could be harnessed for therapeutic benefit [2].”
BackgroundFiorilla, I., Martinotti, S., Todesco, A. M., Bonsignore, G., Cavaletto, M., Patrone, M., Ranzato, E., & Audrito, V. (2023) · Cells · doi:10.3390/cells12162048 · Cited by 39
Zhang, N., Sun, L., Zhou, S., Ji, C., Cui, T., Chu, Q., Ye, J., Liang, S., Ma, K., Liu, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58429-7 · Cited by 34
“Endogenous metabolites are implicated in modulating cellular processes, such as immune homeostasis and tumor development 20,21 .”
Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression
Fukano, M., Park, M., & Deblois, G. (2021) · Cancers · doi:10.3390/cancers13184699 · Cited by 39
Xu, Z.-X., Zhu, X.-M., Yin, H., Li, B., Chen, X., Fan, X.-L., Li, N.-Q., Selosse, M., Gao, J., & Han, J. (2023) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiad198 · Cited by 34
Metformin: update on mechanisms of action on liver diseases
Ruan, G., Wu, F., Shi, D., Sun, H., Wang, F., & Xu, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1327814 · Cited by 34
Metabolic regulation of erythrocyte development and disorders
Lyu, J., Ni, M., Weiss, M. J., & Xu, J. (2024) · Experimental Hematology · doi:10.1016/j.exphem.2024.104153 · Cited by 41
Sakthivel, R., Lin, Y., Yu, M., Dhawan, U., Liu, X., Chen, J.-C., Tung, C., & Chung, R. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113755 · Cited by 37
Immune checkpoint inhibitors in metastatic melanoma therapy (Review)
Shah, V., Panchal, V. S., Shah, A., Vyas, B., Agrawal, S. P., & Bharadwaj, S. P. (2024) · Medicine International · doi:10.3892/mi.2024.137 · Cited by 41
“Other mechanisms responsible for limiting T‑cell trafficking in the tumor microenvironment include mutations in BRAF, and the inhibition of PTEN.”
NF2: An underestimated player in cancer metabolic reprogramming and tumor immunity
Xu, D., Yin, S., & Shu, Y. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00627-5 · Cited by 43
“Intriguingly, they tend to regulate metabolism by adjusting downstream signalling pathways rather than modifying enzymes 168 .”
BackgroundThe Underlying Mechanisms and Emerging Strategies to Overcome Resistance in Breast Cancer
Kannan, K., Srinivasan, A., Kannan, A., & Ali, N. (2025) · Cancers · doi:10.3390/cancers17172938 · Cited by 47
“In fact, mitochondrial respiration and related functions are now understood to be critical for tumor progression and immune evasion [187].”
InfluentialElucidating lipid nanoparticle properties and structure through biophysical analyses
Padilla, M. S., Shepherd, S. J., Hanna, A. R., Kurnik, M., Zhang, X., Chen, M., Byrnes, J., Joseph, R. A., Yamagata, H. M., Ricciardi, A. S., et al. (2025) · Nature Biotechnology · doi:10.1038/s41587-025-02855-x · Cited by 51
“We also investigated LNPs in cancer cells, which have a distinctive cellular biology, especially their cellular metabolism and proliferation 33 .”
Chandran, V. I., Welinder, C., de Oliveira, K. G., Cerezo-Magaña, M., Månsson, A., Johansson, M. C., Marko‐Varga, G., & Belting, M. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03262-4 · Cited by 36
c-Myc directly targets an over-expression of pyruvate carboxylase in highly invasive breast cancer
Lao-On, U., Rojvirat, P., Chansongkrow, P., Phannasil, P., Siritutsoontorn, S., Charoensawan, V., & Jitrapakdee, S. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2019.165656 · Cited by 35
SLC25A32 sustains cancer cell proliferation by regulating flavin adenine nucleotide (FAD) metabolism
Santoro, V., Kovalenko, I., Vriens, K., Christen, S., Bernthaler, A., Haegebarth, A., Fendt, S., & Christian, S. (2020) · Oncotarget · doi:10.18632/oncotarget.27486 · Cited by 40
“To avoid tissue damage, mitochondrial superoxide dismutase 2 (SOD2) rapidly converts O2 - into hydrogen peroxide (H2O2).”
BackgroundMetabolic profiles of regulatory T cells in the tumour microenvironment
Rao, D., Verburg, F., Renner, K., Peeper, D. S., Lacroix, R., & Blank, C. U. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02881-z · Cited by 221
Xue, C., Li, G., Bao, Z., Zhou, Z., & Lan-juan, L. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01996-8 · Cited by 38
Agarwal, E., Goldman, A. R., Tang, H., Kossenkov, A. V., Ghosh, J. C., Languino, L. R., Vaira, V., Speicher, D. W., & Altieri, D. C. (2021) · Science Advances · doi:10.1126/sciadv.abg7287 · Cited by 36
“Consistent with an important role of mitochondria in cancer (5), changes in organelle size, shape, and subcellular distribution, i.”
BackgroundMetabolic therapy and bioenergetic analysis: The missing piece of the puzzle
Duraj, T., Carrión-Navarro, J., Seyfried, T. N., Garcia‐Romero, N., & Ayuso‐Sacido, Á. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101389 · Cited by 42
“Integrating new fi ndings to determine whether glycolysis and OXPHOS can co-occur or are mutually exclusive is under active investigation [149 e 151].”
Nalbantoğlu, S., & Karadağ, A. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114031 · Cited by 39
Wang, S., Hao, H., Jiao, Y., Fu, J., Guo, Z.-W., Guo, Y., Yuan, Y., Li, P., & Han, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.942996 · Cited by 46
“Metabolic reprogramming is a prominent hallmark of cancer cells (Deberardinis and Chandel, 2016).”
BackgroundSp1 promotes tumour progression by remodelling the mitochondrial network in cervical cancer
Xu, X., Wang, X., Chen, Q., Zheng, A., Li, D., Meng, Z., Li, X., Cai, H., Li, W., Huang, S., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04141-3 · Cited by 40
“In addition, hyperactive aerobic glycolysis has been well established as the major metabolic phenotype in cervical cancer and other malignancies [51, 52].”
BackgroundTargeting dysregulated lipid metabolism in the tumor microenvironment
Kim, D., Song, N., & Yim, H. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01473-y · Cited by 44
“…cancer cells and surrounding cells in the TME promotes cancer metastasis and confers chemore-sistance through the establishment of metabolic reprogramming, which involves the alteration of tumor metabolism (DeBerardinis and Chandel 2016; Chen et al. 2022; Li et al. 2022; Liu et al. 2022a, b).”
BackgroundReprogramming of Thyroid Cancer Metabolism: from Mechanism to Therapeutic Strategy
Wan, Y., Li, G., Cui, G., Duan, S., & Chang, S. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02263-4 · Cited by 43
Altered Mitochondrial Signalling and Metabolism in Cancer
Chattopadhyay, E., & Roy, B. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00043 · Cited by 39
“In hypoxic condition, when acetyl CoA production from pyruvate is impaired, glutamine acts as a biosynthetic precursor of acetyl CoA for sustainability of the tumour (40).”
BackgroundLearning from quantitative data to understand central carbon metabolism
Matsuda, F., Toya, Y., & Shimizu, H. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.09.006 · Cited by 39
Cuyàs, E., Fernández‐Arroyo, S., Buxó, M., Pernas, S., Dorca, J., Álvarez, I., Torres‐Martínez, S., Pérez-García, J. M., Batista-López, N., Rodríguez‐Sánchez, C. A., et al. (2019) · Aging · doi:10.18632/aging.101960 · Cited by 34
“Deregulated cellular metabolism is a trait shared by virtually all tumor cells across multiple cancer types, and might be exploited to bypass this therapeutic limitation [5-8].”
BackgroundZhang, C., Liu, T., Luo, P., Gao, L., Liao, X., Ma, L., Jiang, Z., Liu, D., Yang, Z., Jiang, Q., et al. (2021) · Science Advances · doi:10.1126/sciadv.abb6104 · Cited by 34
Metabolic Targeting of Cancer Stem Cells
Mukha, A., & Dubrovska, A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.537930 · Cited by 35
“Since then, many other alterations of biochemical pathways have been described for cancer cells (11, 20, 21).”
BackgroundBasu, H. S., Wilganowski, N. L., Robertson, S., Reuben, J. M., Cohen, E. N., Zurita, A. J., Ramachandran, S., Xiao, L., Titus, M. A., & Wilding, G. (2021) · The Prostate · doi:10.1002/pros.24146 · Cited by 36
“In the last 5 years, the concept of ATP production by fatty acids and/or amino acid oxidation under certain conditions has been realized in cancer cells.(9) Proper maintenance of mitochondrial membrane potential by the ETS is also essential to prevent apoptosis and to support proliferation.”
BackgroundNatarajan, S. R., Ponnusamy, L., & Manoharan, R. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119242 · Cited by 35
Liu, X., Qin, H., Li, Z., Lv, Y., Feng, S., Zhuang, W., Quan, X., Guo, C., Chen, C., & Zhang, H. (2022) · European Respiratory Journal · doi:10.1183/13993003.00062-2022 · Cited by 38
“In recent decades, the advanced metabolic analysis of cancer cells has expanded the understanding of the consequences and mechanisms of cancer metabolism in different stages of tumorigenesis[13, 14].”
Regulation of tumor metabolism by post translational modifications on metabolic enzymes
Dessai, A. S., Kalhotra, P., Novickis, A. T., & Dasgupta, S. (2022) · Cancer Gene Therapy · doi:10.1038/s41417-022-00521-x · Cited by 42
Targeting Mitochondria with ClpP Agonists as a Novel Therapeutic Opportunity in Breast Cancer
Wedam, R., Greer, Y. E., Wisniewski, D. J., Weltz, S., Kundu, M., Voeller, D. M., & Lipkowitz, S. (2023) · Cancers · doi:10.3390/cancers15071936 · Cited by 37
Xu, H., Zuo, S., Wang, D., Zhang, Y., Li, W., Li, L., Liu, T., Yu, Y., Lv, Q., He, Z., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.07.012 · Cited by 33
Tordini, F., Aldinucci, M., Milanesi, L., Lió, P., & Merelli, I. (2016) · Frontiers in Genetics · doi:10.3389/fgene.2016.00194 · Cited by 32
“Considering that metabolic activities are altered in cancer cells and that these alterations support the acquisition and maintenance of malignant properties (DeBerardinis and Chandel, 2016), we also analyzed how many SNPs belong to metabolic genes.”
BackgroundDifferential response to exercise in claudin-low breast cancer
Glass, O. K., Bowie, M., Fuller, J., Darr, D., Usary, J., Boss, K., Choudhury, K. R., Liu, X., Zhang, Z., Locasale, J. W., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.21054 · Cited by 32
“In the C3(1)SV40Tag-p16-luc tumor Hif1 mediated alterations in tumor metabolism may provide an increase in macromolecular precursors for cell proliferation [14].”
BackgroundNiu, N., Ye, J., Hu, Z., Zhang, J., & Wang, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087076 · Cited by 38
Tian, Y., Zhao, L., Gui, Z., Liu, S., Liu, C., Yu, T., & Zhang, L. (2023) · npj Breast Cancer · doi:10.1038/s41523-023-00598-z · Cited by 38
Yan, S., Xue, P., Sun, Y. H., Bai, T., Shao, S., & Zeng, X. (2024) · Advanced Science · doi:10.1002/advs.202409967 · Cited by 43
Reprogramming neuroblastoma by diet-enhanced polyamine depletion
Cherkaoui, S., Turn, C. S., Yuan, Y., Lu, W., Yang, L., McBride, M. J., Eigenmann, C., Allen, G. E., Panasenko, O. O., Zhang, L., et al. (2025) · Nature · doi:10.1038/s41586-025-09564-0 · Cited by 41
Metabolic Reprogramming and Oncogenesis
Costa, A. S. H., & Frezza, C. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.01.001 · Cited by 32
Metabolic Regulation in Mitochondria and Drug Resistance
Pan, Y., Cao, M., Liu, J., Yang, Q. K., Miao, X., Go, V. L. W., Lee, P. W. N., & Xiao, G. G. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-6674-0_11 · Cited by 34
Rafikova, O., Srivastava, A., Desai, A. A., Rafikov, R., & Tofovic, S. P. (2018) · Respiratory Research · doi:10.1186/s12931-018-0776-1 · Cited by 33
“nucleotides leading to uncontrolled proliferation [47].”
A Glycolysis Outsider Steps into the Cancer Spotlight
Goncalves, M. D., & Cantley, L. C. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.017 · Cited by 32
Targeting cancer energy metabolism: a potential systemic cure for cancer
Kim, S. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01115-2 · Cited by 35
Hypoxia-inducible Factor-1α Mediates Hyperglycemia-induced Pancreatic Cancer Glycolysis
Cheng, L., Qin, T., Ma, J., Duan, W., Xu, Q., Li, X., Han, L., Li, W., Wang, Z., Zhang, D., et al. (2019) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520619666190626120359 · Cited by 36
The Human Transient Receptor Potential Melastatin 2 Ion Channel Modulates ROS Through Nrf2
Bao, L., Festa, F., Freet, C. S., Lee, J. P., Hirschler‐Laszkiewicz, I., Chen, S.-J., Keefer, K. A., Wang, H., Patterson, A. D., Cheung, J. Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-50661-8 · Cited by 33
Prostate Cancer Energetics and Biosynthesis
Lin, C., Salzillo, T. C., Bader, D. A., Wilkenfeld, S. R., Awad, D., Pulliam, T. L., Dutta, P., Pudakalakatti, S., Titus, M. A., McGuire, S. E., et al. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_10 · Cited by 39
Modulation of polycystic kidney disease by non-coding RNAs
Ramalingam, H., Yheskel, M., & Patel, V. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109548 · Cited by 35
Kwon, O. K., Ha, Y., Na, A., Chun, S. Y., Kwon, T. G., Lee, J. N., & Lee, S. (2020) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20180 · Cited by 32
Agarwal, S., Chakravarthi, B. V. S. K., Kim, H., Gupta, N., Hale, K., Balasubramanya, S. A. H., Oliver, P. G., Thomas, D. G., Eltoum, I. A., Buchsbaum, D. J., et al. (2020) · Translational Oncology · doi:10.1016/j.tranon.2020.100776 · Cited by 35
“Transcription factors and metabolic enzymes that induce alterations in cancer metabolism could be targets for cancer therapy [47].”
BackgroundRepression of LKB1 by miR-17∼92 Sensitizes MYC-Dependent Lymphoma to Biguanide Treatment
Izreig, S., Gariepy, A., Kaymak, I., Bridges, H. R., Donayo, A. O., Bridon, G., DeCamp, L. M., Kitchen-Goosen, S. M., Avizonis, D. Z., Sheldon, R. D., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100014 · Cited by 34
“Oncogene activation or tumor suppressor inactivation promotes changes in cellular metabolism that facilitate transformation and tumor cell proliferation.(2) However, the increased metabolic activity stimulated by transformation imposes additional stresses on tumor cells, such as nutrient depletion and redox imbalance,…”
Metabolic regulation in HPV associated head and neck squamous cell carcinoma
Chandel, V., Raj, S., Kumar, P., Gupta, S., Dhasmana, A., Kesari, K. K., Ruokolainen, J., Mehra, P., Das, B. C., Kamal, M. A., et al. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118236 · Cited by 34
“Adenosine triphosphate (ATP) provide energy to the cells and that utilize through carbohydrate, protein and fat metabolism [35].”
Tang, Y., Yang, X., Feng, K., Hu, C.-L., & Li, S. (2021) · Journal of Gastrointestinal Oncology · doi:10.21037/jgo-20-534 · Cited by 33
“It is well known that glycolysis is the main source of energy for the survival of cancer cells (11).”
BackgroundGarcía‐Cañaveras, J. C., & Lahoz, A. (2021) · Cancers · doi:10.3390/cancers13133230 · Cited by 38
“However, mutations in the metabolic enzymes isocitrate dehydrogenase 1/2 (IDH1/2), fumarate hydratase (FH) and succinate dehydrogenase (SDH) also result in oncogenic transformation through mechanisms exerted by the accumulation of oncometabolites D-2hydroxyglutarate (D-2HG), fumarate and succinate, respectively [3,5].”
BackgroundChisari, A. N., Golán, I., Campisano, S., Gélabert, C., Moustakas, A., Sancho, P., & Caja, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.723798 · Cited by 37
Govoni, M., Rossi, V. S., Stefano, G. D., & Manerba, M. (2021) · Pathology & Oncology Research · doi:10.3389/pore.2021.1609951 · Cited by 33
“The activated glucose metabolism of cancer cells is functional in coping with their increased energy demand and need of metabolic intermediates, required to build-up new macromolecules [1,2].”
BackgroundMagisetty, R., & Park, S. (2022) · Micromachines · doi:10.3390/mi13020161 · Cited by 39
Oxidative Stress and Immune Response in Melanoma: Ion Channels as Targets of Therapy
Remigante, A., Spinelli, S., Marino, A., Pusch, M., Morabito, R., & Dossena, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24010887 · Cited by 39
“The process that converts indoles to quinones implicates an important generation of reactive oxygen species (O2 and H2O2) (Figure 1) [56,57].”
BackgroundA Potential “Anti-Warburg Effect” in Circulating Tumor Cell-mediated Metastatic Progression?
Jiang, Z., He, J., Zhang, B., Wang, L., Long, C., Zhao, B., Yang, Y., Du, L., Luo, W., Hu, J., et al. (2024) · Aging and Disease · doi:10.14336/ad.2023.1227 · Cited by 47
Hou, M., Zhao, Z., Li, S., Zhang, Z., Li, X., Zhang, Y., Huang, W., Li, L., Xi, W., Liang, F., et al. (2024) · Journal of Cancer · doi:10.7150/jca.102045 · Cited by 34
“Cancer progression is governed by complex intracellular signaling networks, where multiple pathways intersect to regulate tumor cell phenotypes[12-14].”
The role of acetylation and deacetylation in cancer metabolism
Wang, C., & Ma, X. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70145 · Cited by 42
“22 Early studies revealed that the oncogene ras can induce the expression of glucose transporters, enabling cancer cells to take up large amounts of glucose to meet their abnormal energy demands.”
Hansen, A. E., Gutte, H., Holst, P., Johannesen, H. H., Rahbek, S., Clemmensen, A., Larsen, M., Schøier, C., Ardenkjær‐Larsen, J. H., Klausen, T. L., et al. (2018) · European Journal of Radiology · doi:10.1016/j.ejrad.2018.02.028 · Cited by 33
“The aerobic glycolysis generally exhibited by cancer cells can occur while the cells still use glucose to produce ATP in the mitochondria [8,24,25,29].”
BackgroundBishnu, A., Sakpal, A., Ghosh, N., Choudhury, P., Chaudhury, K., & Ray, P. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.12.016 · Cited by 32
Walsh, H. R., Cruickshank, B. M., Brown, J. M., & Marcato, P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00753 · Cited by 35
“To accomplish this, transformed cells must increase the production of biomolecules needed and extract elevated quantities of nutrients from the surrounding environment (2).”
BackgroundCombinatorial targeting of MTHFD2 and PAICS in purine synthesis as a novel therapeutic strategy
Cheung, C. H. Y., Hsu, C., Tsuei, C.-Y., Kuo, T., Huang, C.-T., Hsu, W., Chung, Y.-H., Wu, H.-Y., Hsu, C., Huang, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-2033-z · Cited by 35
Gammon, S. T., Pisaneschi, F., Bandi, M. L., Smith, M. G., Sun, Y., Rao, Y., Müller, F. L., Wong, F. C., de Groot, J., Ackroyd, J. J., et al. (2019) · Cells · doi:10.3390/cells8121487 · Cited by 34
“These clinical studies also complement recent reports that emphasize the complexity of tumor metabolic reprogramming; not only do tumor cells utilize OxPhos, but some also depend upon OxPhos for both energy and anabolism [21–29].”
Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism
Cho, E. S., Kim, N. H., Yun, J. S., Cho, S. B., Kim, H. S., & Yook, J. I. (2020) · Cells · doi:10.3390/cells9092064 · Cited by 32
Sun, R., Gu, J., Chang, X., Liu, F., Liang, Y., Yang, X., Li, L., & Tang, D. (2020) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2020.113708 · Cited by 34
Jones, A. E., Li, S., Acevedo, A., Veliova, M., Shirihai, O. S., Stiles, L., & Divakaruni, A. S. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00235.2020 · Cited by 37
Gu, C., Liu, J., Liu, X., Zhang, H., Luo, J., Wang, H., Locasale, J. W., & Shears, S. B. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2020187118 · Cited by 33
“Tumor cells consistently reprogram metabolic pathways to cope with both genetic alterations and environmental challenges that threaten cell survival and proliferation (1, 2).”
BackgroundA pan-cancer transcriptomic study showing tumor specific alterations in central metabolism
Sheraj, I., Güray, T., & Banerjee, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-93003-3 · Cited by 33
Reprogramming of tissue metabolism during cancer metastasis
Ganguly, K., & Kimmelman, A. C. (2023) · Trends in cancer · doi:10.1016/j.trecan.2023.02.005 · Cited by 36
Repurposing drugs targeting metabolic diseases for cancer therapeutics
Pillai U, J., Ray, A., Maan, M., & Dutta, M. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103684 · Cited by 31
Śmiełowska, M., Ligor, T., Kupczyk, W., Szeliga, J., Jackowski, M., & Buszewski, B. (2023) · Journal of Breath Research · doi:10.1088/1752-7163/ace46e · Cited by 34
“In the case of cancer cells, altered metabolism is observed, involving often increased glucose and glutamine consumption, increased glycolysis, changes in the use of metabolic enzyme isoforms, and increased secretion of lactate [11, 12].”
BackgroundOverexpression of the human DEK oncogene reprograms cellular metabolism and promotes glycolysis
Matrka, M. C., Watanabe, M., Muraleedharan, R., Lambert, P. F., Lane, A. N., Romick‐Rosendale, L. E., & Wells, S. I. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177952 · Cited by 32
Metabolic Remodeling Induced by Adipocytes: A New Achilles' Heel in Invasive Breast Cancer?
Attané, C., Milhas, D., Hoy, A. J., & Muller, C. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180426165001 · Cited by 34
Rupprecht, A., Moldzio, R., Mödl, B., & Pohl, E. E. (2019) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2019.03.006 · Cited by 32
“These less understood mechanisms adjust cellular metabolism in situations like nutrient limitation that take place during tumor growth [7,8].”
Background
Metadata
- Authors
- DeBerardinis, R. J., & Chandel, N. S.
- Affiliations
- Children's Medical Center (US)
- Northwestern University (US)
- Corresponding author
- DeBerardinis, Ralph J.
- Chandel, Navdeep S.
- Venue
- Science Advances
- Published
- 2016-05-06
- Volume
- 2
- Issue
- 5
- Pages
- e1600200-e1600200
- ISSN
- 2375-2548 (ISSN-L)
- PMC
- PMC4928883
- OpenAlex
- W2395626624
- Semantic Scholar
- bebecd5b21653ab07940aa17ec319c54e710f9dc
- Cited by
- 3,013
- References
- 204
- Citations by year
- 2026: 271 · 2025: 296 · 2024: 326 · 2023: 359 · 2022: 427 · 2021: 447 · 2020: 340 · 2019: 257 · 2018: 166 · 2017: 109 · 2016: 12
- FWCI
- 16.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- Science Advances (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (ID0E1EAG7327, R01 CA123067)
- National Cancer Institute (ID0EAMAG7328, 5R01CA157996)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- cancer metabolism, metabolic reprogramming, tumor bioenergetics, redox metabolism, nutrient acquisition, carcinogenesis, metastasis, cancer therapy
- MeSH terms
- Animals, Energy Metabolism, Humans, Mitochondria, Neoplasms, Oxidation-Reduction, Signal Transduction, Reactive Oxygen Species, Macromolecular Substances, Metabolic Networks and Pathways, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.